Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-25-009895
Filing Date
2025-02-06
Accepted
2025-02-06 08:00:15
Documents
6
Period of Report
2025-02-06

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm255706d1_6k.htm 6-K 13341
2 EXHIBIT 1.1 tm255706d1_ex1-1.htm EX-1.1 178449
3 EXHIBIT 1.2 tm255706d1_ex1-2.htm EX-1.2 61726
4 EZHIBIT 4.1 tm255706d1_ex4-1.htm EX-4.1 92044
5 EXHIBIT 99.1 tm255706d1_ex99-1.htm EX-99.1 8677
6 GRAPHIC tm255706d1_ex99-1img001.jpg GRAPHIC 3036
  Complete submission text file 0001104659-25-009895.txt   359624
Mailing Address 12750 HIGH BLUFF DRIVE SUITE 475 SAN DIEGO CA 92130
Business Address 12750 HIGH BLUFF DRIVE SUITE 475 SAN DIEGO CA 92130 858-246-6240
BELITE BIO, INC (Filer) CIK: 0001889109 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41359 | Film No.: 25595506
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)